Hyderabad Pharma City Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Ebitda
- Net Worth -41.84%
(FY 2019)
- Total Assets %
(FY 2019)
About Hyderabad Pharma City
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hyderabad Pharma City Limited India is Shakthi Nagappan as CEO. Jayesh Ranjan, Om Agarwal, Venkat Ettireddy, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999TG2017SGC115902
- Company No.
115902
- Company Classification
Private Limited State Government Company
- Incorporation Date
15 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hyderabad Pharma City?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakthi Nagappan  | CEO | 29-Apr-2022 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kappuram Shyam | Director | 07-Aug-2018 | Current |
| Jayesh Ranjan | Director | 29-Apr-2022 | Current |
| Om Agarwal | Director | 30-Dec-2022 | Current |
| Venkat Ettireddy | Director | 15-Mar-2017 | Current |
| Shakthi Nagappan | Additional Director and Ceo | 29-Apr-2022 | Current |
| Dharmagadda Ravi | Director | 03-Jun-2017 | Current |
Financial Performance and Corporate Structure Insights of Hyderabad Pharma City.
Hyderabad Pharma City Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hyderabad Pharma City?
In 2023, Hyderabad Pharma City had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Telangana State Trade Promotion Corporation LimitedActive 10 years 2 monthsJayesh Ranjan and Venkat Ettireddy are mutual person
Telangana State Industrial Infrastructure Corporation LimitedActive 10 years 3 monthsJayesh Ranjan and Venkat Ettireddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hyderabad Pharma City?
Unlock and access historical data on people associated with Hyderabad Pharma City, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Pharma City, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Pharma City's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
